EUCOPE - European Confederation of Pharmaceutical Entrepreneurs

🌍 Building a Competitive & Innovative Pharmaceutical Ecosystem for the EU   As the EU looks ahead to the next decades, it's crucial to prepare the European pharmaceutical sector to tackle emerging challenges and seize new opportunities.    ✒️ By signing EUCOPE - European Confederation of Pharmaceutical Entrepreneurs’s open letter to the Presidents of the European Commission, European Parliament, and Council of the European Union, 24 EUCOPE members urge the EU Institutions and Member States to collaborate in creating a competitive and attractive pharmaceutical landscape. 🏥✨    🔬 To remain globally competitive, pharmaceutical companies need a robust, predictable and strong investment and industrial ecosystem.    💊  Special emphasis should be placed on small and mid-sized innovative companies, which are pivotal in driving technology and medical advancements across Europe.    #PharmaInnovation #EUPharma #InnovationEcosystem #RareDiseases    👓 Read the open letter here: 👉 https://lnkd.in/eCeJk8U5   Alexion Pharmaceuticals, Inc. Amgen Angelini Pharma AOP Health Biogen BioMarin Pharmaceutical Inc. Blueprint Medicines Chiesi Group Circius Pharma CSL Emergent BioSolutions Incyte Insmed Incorporated MENARINI Group Miltenyi Biomedicine MSD Norgine Orion Corporation Sanofi Santen Shionogi Europe Sobi - Swedish Orphan Biovitrum AB (publ) Takeda

🚨 EUCOPE New members! ⭐ EUCOPE is honoured to announce Avidity Biosciences, Inc. and Decisive Consulting Ltd as new members! 🔬 We're proud to count on their expertise in our network to enhance the representation of small and mid-sized innovative companies. 🧪 In these critical times, we look forward to working together to advance #InnovativeTherapies and #MedicalTechnologies that improve and save the lives of #EuropeanPatients. Pharmaceutical innovators, here are 4️⃣ great reasons to join EUCOPE: 🔗 A strong #network 📢 #Advocacy & evaluation 🌍 European #expertise 🎯 Increased #visibility Learn more about EUCOPE membership: https://lnkd.in/esQQTxXe #EUCOPE #PharmaInnovation #Healthcare #PatientCare #MedicalTechnology #RNAtherapies

📢 Join EUCOPE's Senior Legal and Regulatory Affairs Manager, Dr. Seán Byrne tomorrow at the EMA SME Info Day ! ⚕️ 💡 The hybrid event held by the European Medicines Agency will be the opportunity to discuss the following key points: 🔹 #ScientificAdvice 🔹 #ClinicalTrials 🔹 #MedicalDevices 🔹 The new #EUHTA 🔹 #EMAFeeRegulations 🔹 Addressing #MedicineShortages To share your views on the impact of these topics on your business, or to receive more information, please reach out to our expert: 📲 Dr. Seán Byrne  📨 byrne@eucope.org 👉 Information and registration: https://lnkd.in/eqrsesVM #PharmaSMEs #PharmaInnovation #EURegulations #EMAInfoDay

🌟 EUCOPE is excited for the upcoming European Medicines Agency SME Info Day on 18 October 2024! This hybrid event is tailored for small and medium-sized enterprises (SMEs) in the pharmaceutical sector, offering key updates on: #ScientificAdvice #ClinicalTrials #MedicalDevices The new #EUHTA #EMAFeeRegulations Addressing #MedicineShortages 💡 Don't miss the chance to engage directly with EMA experts during the "Meet EMA" session, where SMEs can learn more about essential support tools for medicine development. 🗨️ If you'd like to discuss how these updates impact your business, reach out to EUCOPE's Senior Legal and Regulatory Affairs Manager, Dr. Seán Byrne, in advance or on the day at byrne@eucope.org. 👉Information and registration: https://lnkd.in/eqrsesVM #PharmaSMEs #PharmaInnovation #EURegulations #EMAInfoDay

The latest International Rare Diseases Research Consortium (IRDiRC) publication, "Leaving no patient behind! Expert recommendation in the use of innovative technologies for diagnosing rare diseases", is now live on Orphanet Journal of Rare Diseases with open access! This paper offers key insights and expert guidance on how cutting-edge technologies can revolutionise rare disease diagnostics. A valuable resource for anyone invested in advancing rare disease diagnosis and care. 🔗 https://lnkd.in/eMWbjtHC #RareDiseases #InnovativeDiagnosis #TechForGood #OpenAccess #IRDiRC

📅 EUCOPE are excited for the next edition of the European Medicines Agency #SME Info Day, Friday October 18th.    📍 A lot of exciting topics and updates to be covered including:  🔹 #ScientificAdvice 🔹 #ClinicalTrials 🔹 #HTA 🔹 #MedicalDevices 🔹 New EMA Fee Regulation 🔹 Management of Shortages 📨 Be sure to catch up with Dr. Seán Byrne on the day or get in-touch in advance at byrne@eucope.org. 👉 More information and registration: https://lnkd.in/eqrsesVM #PharmaSME #MedicinesRegulation #EMA #EUCOPE #HealthInnovation

🗓️ SAVE THE DATE! 🗓️ The TRANSFORM MEP Interest Group is delighted to announce its annual conference is taking place on Thursday 21 November 2024. Host MEP Billy Kelleher will re-launch 🚀 the MEP Interest Group, and be joined by experts and Alliance members to discuss the future of #ATMPs 🧬 in the new mandate. 📝 Registration opens today - we hope you can join us in-person or online! #MEPsforATMPs 🕰️ 10:00-13:30 📍 Brussels and online 🔗 Register via our website: https://lnkd.in/e5XfpZRH

📢 EUCOPE looks forward to the next European Medicines Agency (EMA) SME Info Day on 18 October 2024! This hybrid event is dedicated to small and medium-sized enterprises (SMEs) in the pharmaceutical sector, covering key updates on EMA #ScientificAdvice, #ClinicalTrials, #MedicalDevices, the new #EUHTA and #EMAFeeRegulations, and addressing #MedicineShortages. 💡 Plus, SMEs will have the opportunity to connect directly with EMA staff during the "Meet EMA" session, gaining insights on valuable support tools for medicine development. Contact EUCOPE's Senior Legal and Regulatory Affairs Manager, Dr. Seán Byrne on the day itself or in advance at byrne@eucope.org More information and registration:  https://lnkd.in/eqrsesVM #PharmaSME #MedicinesRegulation #EMA #EUCOPE #HealthInnovation

On 2️⃣ 4️⃣  September, Dr. Seán Byrne participated in the Office of Health Economics webinar "Drug Shortages: What are the causes, consequences and pathways to a solution?". With expert panelists, he discussed:  🔸The root causes and costs of drug shortages, and their far-reaching consequences; 🔸International government policy measures aimed at ensuring a sustainable and resilient medicine supply; 🔸The shift from managing drug shortages to preventing them altogether. ❔ Missed the session? 🎥 Watch the recordings now:  https://lnkd.in/d2FN3Ns9 #DrugShortagesCrisis #HealthcareResilience #GlobalMedicineSupply #PreventDrugShortages #SustainablePharma #MedicineAccessForAll #PolicyForDrugSupply #PharmaSupplyChain #TacklingDrugShortages #PreventiveHealthcarePolicies

🗞️ New EUCOPE Publication 🗞️ 🔬 EUCOPE Secretary General Alexander Natz published an op-ed in the The Parliament outlining EUCOPE's vision for a strong and competitive #PharmaceuticalFramework, especially advocating for the needs of small and mid-sized companies. 🧬 These companies are pivotal to driving #innovation and bringing groundbreaking #therapies to #patients. 📢 EUCOPE, as representative of innovative pharmaceutical companies, calls for an investment, regulatory, and industrial ecosystem that is not only robust but also predictable, addressing the unique challenges and opportunities these companies face. 👉 Read the complete article now: https://lnkd.in/euYDrHKi #PharmaInnovation #EUHealthcare #LifeSciences #FutureOfHealthcare